PepGen Ltd (PEPG)
Healthcare
Biotechnology
1.90 $
+6.8%
vs. previous close
Closing price · As of: 3. Aug 2026
PepGen Ltd (PEPG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -16 | -19 | -23 | -16 | -24 | -19 | -23 | -24 | -19 | -16 | -18 | -77 | |
| 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 1.3 | 0.4 | 1.3 | 1.3 | 1.3 | 1.3 | 0.3 | 4.1 | |
| 1.8 | 1.9 | 1.9 | 2.0 | 2.9 | 3.2 | 3.3 | 3.4 | 2.4 | 2.4 | 2.4 | 2.9 | 10 | |
| 1.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.2 | 4.6 | -1.9 | -6.3 | 7.9 | -1.6 | -0.9 | 3.2 | -4.4 | -4.6 | -0.4 | -4.0 | -13 | |
| 1.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | |
| -1.0 | -0.2 | -30 | -11 | -53 | -0.1 | 27 | 17 | 15 | 19 | -66 | -1.5 | -34 | |
| 0.2 | -0.5 | 0.0 | 87 | 1.3 | 0.3 | 0.1 | 0.0 | 0.1 | 108 | -0.2 | 1.5 | 109 | |
| -18 | -17 | -49 | 53 | -68 | -24 | 7.1 | -5.8 | -8.6 | 108 | -82 | -18 | -1.5 | |
| -19 | -17 | -20 | -23 | -16 | -24 | -20 | -23 | -24 | -19 | -16 | -18 | -77 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.